← FDA DRUG APPROVALS

FDA ANDA · ANDA084340

TRIAMCINOLONE

Sponsor: IMPAX LABS

APPLICATION
ANDA084340
TYPE
ANDA
ORIGINAL APPROVAL
1975-04-22
LATEST ACTION
1992-03-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONEDiscontinued
TRIAMCINOLONE 4MG · TABLET · ORAL

Approval history

1992-03-13Labeling · Supplement 39AP
1992-03-13Labeling · Supplement 41AP
1990-05-25Labeling · Supplement 38AP
1989-05-19Labeling · Supplement 37AP
1975-04-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →